META-ANALYSIS OF THE CARDIOVASCULAR OUTCOMES WITH DIPEPTIDYL PEPTIDASE 4 INHIBITORS: VALIDATION OF THE CURRENT FDA MANDATE
2014 ◽
Vol 63
(12)
◽
pp. A1335
◽
2014 ◽
Vol 63
(12)
◽
pp. A1337
2014 ◽
Vol 32
(4)
◽
pp. 147-158
◽
2014 ◽
Vol 14
(3)
◽
pp. 191-207
◽
2015 ◽
Vol 181
◽
pp. 239-244
◽
2019 ◽
Vol 149
◽
pp. 47-63
◽
2015 ◽
Vol 110
◽
pp. S10